Europe Fill Finish Manufacturing Market Forecast to 2030 - Regional Analysis - by Product (Consumables {Prefilled Syringes, Glass Vial/Plastic Vials, Cartridges, and Others} and Instruments), Modality (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others), and End User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Others)
The Europe fill finish manufacturing market was valued at US$ 2,473.26 million in 2022 and is expected to reach US$ 4,772.50 million by 2030; it is estimated to grow at a CAGR of 8.6% from 2022 to 2030.
Elevating Demand for Biologics Drives Europe Fill Finish Manufacturing Market
Biologics constitute a majority of the top-selling drugs, and they represent one of the fastest-growing pharmaceutical industry segments. Since the launch of recombinant protein-based therapies ~30 years ago, the overall biologics market has grown at an annual rate of more than 12%. Further, over 5,000 biopharmaceutical product candidates are currently under development. Although biopharmaceuticals offer significant profit margins, high development costs and complex production protocols are the key concerns of the sponsors of these pharmacological interventions. As a result, several start-ups and pharmaceutical giants have begun outsourcing different processes of their business operations to contract service providers. Moreover, outsourcing jobs to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) reduces the requirement of capital investments, provides access to larger production capacities, decreases the time-to-market of products, and lowers risks associated with the commercialization of products.
Fill finish is the final step in the production process, and it is one of the most crucial stages of drug manufacturing. Biologics require special procedures and equipment for fill finish operations to ensure product integrity and safety. Thus, the rise in demand for biologics has resulted in an equivalent need for flexible aseptic fill finish technologies. Pharmaceutical drug manufacturers collaborate with contract service providers to leverage their experience and expertise in the latest fill finish technologies. Fill finish manufacturing services are currently provided by approximately 180 companies for a variety of biologics. They are located in over 350 fill finish factories for these contract manufacturing companies across various geographic regions.
Europe Fill Finish Manufacturing Market Overview
The market players in Germany are adopting organic and inorganic growth strategies for market expansion and growth. For instance, in July 2020, Vetter, the contract development and manufacturing organization (CDMO), headquarters in Ravensburg, Germany, announced that it is investing in additional fill/finish capacity with the purchase of a clinical manufacturing site in Austria.
Similarly, The Siegfried Group signed a cooperation and supply agreement with Biopharmaceutical New Technologies, a German immunotherapy company, for the large-scale filling and packaging of commercial quantities of BNT162b2, an innovative COVID-19 vaccine candidate. Following successful approval, the vaccine developed by BioNTech in cooperation with Pfizer, an American pharmaceutical company, will be filled by Siegfried at its Hameln site from mid-2021 onwards. Also, Rentschler Biotechnologie GmbH, leading contract development and manufacturing organization (CDMO) for biopharmaceuticals located in Germany, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the requirements of Rentschler Biotechnologie's clients.
Europe Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)
Europe Fill Finish Manufacturing Market Segmentation
The Europe fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Europe fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.
By modality, the Europe fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.
In terms of end user, the Europe fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.
Based on country, the Europe fill finish manufacturing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fill finish manufacturing market share in 2022.
Becton Dickinson and Co, Gerresheimer AG, Groninger and Co GmbH, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Europe fill finish manufacturing market.
Elevating Demand for Biologics Drives Europe Fill Finish Manufacturing Market
Biologics constitute a majority of the top-selling drugs, and they represent one of the fastest-growing pharmaceutical industry segments. Since the launch of recombinant protein-based therapies ~30 years ago, the overall biologics market has grown at an annual rate of more than 12%. Further, over 5,000 biopharmaceutical product candidates are currently under development. Although biopharmaceuticals offer significant profit margins, high development costs and complex production protocols are the key concerns of the sponsors of these pharmacological interventions. As a result, several start-ups and pharmaceutical giants have begun outsourcing different processes of their business operations to contract service providers. Moreover, outsourcing jobs to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) reduces the requirement of capital investments, provides access to larger production capacities, decreases the time-to-market of products, and lowers risks associated with the commercialization of products.
Fill finish is the final step in the production process, and it is one of the most crucial stages of drug manufacturing. Biologics require special procedures and equipment for fill finish operations to ensure product integrity and safety. Thus, the rise in demand for biologics has resulted in an equivalent need for flexible aseptic fill finish technologies. Pharmaceutical drug manufacturers collaborate with contract service providers to leverage their experience and expertise in the latest fill finish technologies. Fill finish manufacturing services are currently provided by approximately 180 companies for a variety of biologics. They are located in over 350 fill finish factories for these contract manufacturing companies across various geographic regions.
Europe Fill Finish Manufacturing Market Overview
The market players in Germany are adopting organic and inorganic growth strategies for market expansion and growth. For instance, in July 2020, Vetter, the contract development and manufacturing organization (CDMO), headquarters in Ravensburg, Germany, announced that it is investing in additional fill/finish capacity with the purchase of a clinical manufacturing site in Austria.
Similarly, The Siegfried Group signed a cooperation and supply agreement with Biopharmaceutical New Technologies, a German immunotherapy company, for the large-scale filling and packaging of commercial quantities of BNT162b2, an innovative COVID-19 vaccine candidate. Following successful approval, the vaccine developed by BioNTech in cooperation with Pfizer, an American pharmaceutical company, will be filled by Siegfried at its Hameln site from mid-2021 onwards. Also, Rentschler Biotechnologie GmbH, leading contract development and manufacturing organization (CDMO) for biopharmaceuticals located in Germany, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the requirements of Rentschler Biotechnologie's clients.
Europe Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)
Europe Fill Finish Manufacturing Market Segmentation
The Europe fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Europe fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.
By modality, the Europe fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.
In terms of end user, the Europe fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.
Based on country, the Europe fill finish manufacturing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fill finish manufacturing market share in 2022.
Becton Dickinson and Co, Gerresheimer AG, Groninger and Co GmbH, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Europe fill finish manufacturing market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE FILL FINISH MANUFACTURING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. EUROPE FILL FINISH MANUFACTURING MARKET - KEY INDUSTRY DYNAMICS
5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
5.2 Key Market Drivers
5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
5.2.2 Elevating Demand for Biologics
5.3 Key Market Restraints
5.3.1 Growing Competition in Biopharmaceutical Contract Manufacturing Industry
5.4 Key Market Opportunities
5.4.1 Significant Pipeline for Biologics
5.5 Key Future Trends
5.5.1 Single-Use Systems for Aseptic Fill Finish
5.6 Impact of Drivers and Restraints:
6. FILL FINISH MANUFACTURING MARKET - EUROPE MARKET ANALYSIS
7. EUROPE FILL FINISH MANUFACTURING MARKET ANALYSIS - PRODUCT
7.1 Consumables
7.1.1 Overview
7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
8. EUROPE FILL FINISH MANUFACTURING MARKET ANALYSIS - MODALITY
8.1 Recombinant Proteins
8.1.1 Overview
8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Monoclonal Antibodies
8.2.1 Overview
8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Vaccines
8.3.1 Overview
8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Cell Therapies and Biological Therapies
8.4.1 Overview
8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Gene Therapies
8.5.1 Overview
8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. EUROPE FILL FINISH MANUFACTURING MARKET ANALYSIS - END USER
9.1 Contract Manufacturing Organizations
9.1.1 Overview
9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. EUROPE FILL FINISH MANUFACTURING MARKET - COUNTRY ANALYSIS
10.1 Europe Fill Finish Manufacturing Market Breakdown, by Country
10.1.1 United Kingdom
10.1.2 United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.2.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Product
10.1.2.1.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Consumables
10.1.2.2 United Kingdom Fill Finish Manufacturing Market Breakdown by Modality
10.1.2.3 United Kingdom Fill Finish Manufacturing Market Breakdown by End User
10.1.3 Germany
10.1.4 Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.4.1 Germany Fill Finish Manufacturing Market Breakdown by Product
10.1.4.1.1 Germany Fill Finish Manufacturing Market Breakdown by Consumables
10.1.4.2 Germany Fill Finish Manufacturing Market Breakdown by Modality
10.1.4.3 Germany Fill Finish Manufacturing Market Breakdown by End User
10.1.5 France
10.1.6 France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.6.1 France Fill Finish Manufacturing Market Breakdown by Product
10.1.6.1.1 France Fill Finish Manufacturing Market Breakdown by Consumables
10.1.6.2 France Fill Finish Manufacturing Market Breakdown by Modality
10.1.6.3 France Fill Finish Manufacturing Market Breakdown by End User
10.1.7 Italy
10.1.7.1 Italy Fill Finish Manufacturing Market Breakdown by Product
10.1.7.1.1 Italy Fill Finish Manufacturing Market Breakdown by Consumables
10.1.7.2 Italy Fill Finish Manufacturing Market Breakdown by Modality
10.1.7.3 Italy Fill Finish Manufacturing Market Breakdown by End User
10.1.8 Spain
10.1.9 Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.9.1 Spain Fill Finish Manufacturing Market Breakdown by Product
10.1.9.1.1 Spain Fill Finish Manufacturing Market Breakdown by Consumables
10.1.9.2 Spain Fill Finish Manufacturing Market Breakdown by Modality
10.1.9.3 Spain Fill Finish Manufacturing Market Breakdown by End User
10.1.10 Rest of Europe
10.1.11 Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.11.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Product
10.1.11.1.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Consumables
10.1.11.2 Rest of Europe Fill Finish Manufacturing Market Breakdown by Modality
10.1.11.3 Rest of Europe Fill Finish Manufacturing Market Breakdown by End User
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 IMA Industria Macchine Automatiche SpA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Nipro Medical Europe NV
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Maquinaria Industrial Dara SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Groninger and Co GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SGD SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Optima Packaging Group Gmbh
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 NNE AS
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Product & Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Stevanato Group SpA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Syntegon Technology GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 West Pharmaceutical Services Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Gerresheimer AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Schott AG
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Becton Dickinson and Co
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE FILL FINISH MANUFACTURING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. EUROPE FILL FINISH MANUFACTURING MARKET - KEY INDUSTRY DYNAMICS
5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
5.2 Key Market Drivers
5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
5.2.2 Elevating Demand for Biologics
5.3 Key Market Restraints
5.3.1 Growing Competition in Biopharmaceutical Contract Manufacturing Industry
5.4 Key Market Opportunities
5.4.1 Significant Pipeline for Biologics
5.5 Key Future Trends
5.5.1 Single-Use Systems for Aseptic Fill Finish
5.6 Impact of Drivers and Restraints:
6. FILL FINISH MANUFACTURING MARKET - EUROPE MARKET ANALYSIS
7. EUROPE FILL FINISH MANUFACTURING MARKET ANALYSIS - PRODUCT
7.1 Consumables
7.1.1 Overview
7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
8. EUROPE FILL FINISH MANUFACTURING MARKET ANALYSIS - MODALITY
8.1 Recombinant Proteins
8.1.1 Overview
8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Monoclonal Antibodies
8.2.1 Overview
8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Vaccines
8.3.1 Overview
8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Cell Therapies and Biological Therapies
8.4.1 Overview
8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Gene Therapies
8.5.1 Overview
8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. EUROPE FILL FINISH MANUFACTURING MARKET ANALYSIS - END USER
9.1 Contract Manufacturing Organizations
9.1.1 Overview
9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. EUROPE FILL FINISH MANUFACTURING MARKET - COUNTRY ANALYSIS
10.1 Europe Fill Finish Manufacturing Market Breakdown, by Country
10.1.1 United Kingdom
10.1.2 United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.2.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Product
10.1.2.1.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Consumables
10.1.2.2 United Kingdom Fill Finish Manufacturing Market Breakdown by Modality
10.1.2.3 United Kingdom Fill Finish Manufacturing Market Breakdown by End User
10.1.3 Germany
10.1.4 Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.4.1 Germany Fill Finish Manufacturing Market Breakdown by Product
10.1.4.1.1 Germany Fill Finish Manufacturing Market Breakdown by Consumables
10.1.4.2 Germany Fill Finish Manufacturing Market Breakdown by Modality
10.1.4.3 Germany Fill Finish Manufacturing Market Breakdown by End User
10.1.5 France
10.1.6 France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.6.1 France Fill Finish Manufacturing Market Breakdown by Product
10.1.6.1.1 France Fill Finish Manufacturing Market Breakdown by Consumables
10.1.6.2 France Fill Finish Manufacturing Market Breakdown by Modality
10.1.6.3 France Fill Finish Manufacturing Market Breakdown by End User
10.1.7 Italy
10.1.7.1 Italy Fill Finish Manufacturing Market Breakdown by Product
10.1.7.1.1 Italy Fill Finish Manufacturing Market Breakdown by Consumables
10.1.7.2 Italy Fill Finish Manufacturing Market Breakdown by Modality
10.1.7.3 Italy Fill Finish Manufacturing Market Breakdown by End User
10.1.8 Spain
10.1.9 Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.9.1 Spain Fill Finish Manufacturing Market Breakdown by Product
10.1.9.1.1 Spain Fill Finish Manufacturing Market Breakdown by Consumables
10.1.9.2 Spain Fill Finish Manufacturing Market Breakdown by Modality
10.1.9.3 Spain Fill Finish Manufacturing Market Breakdown by End User
10.1.10 Rest of Europe
10.1.11 Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.11.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Product
10.1.11.1.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Consumables
10.1.11.2 Rest of Europe Fill Finish Manufacturing Market Breakdown by Modality
10.1.11.3 Rest of Europe Fill Finish Manufacturing Market Breakdown by End User
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 IMA Industria Macchine Automatiche SpA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Nipro Medical Europe NV
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Maquinaria Industrial Dara SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Groninger and Co GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SGD SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Optima Packaging Group Gmbh
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 NNE AS
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Product & Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Stevanato Group SpA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Syntegon Technology GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 West Pharmaceutical Services Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Gerresheimer AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Schott AG
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Becton Dickinson and Co
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
